MediPharm Labs Corp. (OTCMKTS:MEDIF) Short Interest Update

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the recipient of a large decline in short interest in March. As of March 15th, there was short interest totalling 205,100 shares, a decline of 30.1% from the February 28th total of 293,300 shares. Based on an average daily volume of 173,600 shares, the short-interest ratio is presently 1.2 days.

MediPharm Labs Stock Down 2.1 %

MEDIF traded down $0.00 during trading on Friday, hitting $0.07. The company’s stock had a trading volume of 328,795 shares, compared to its average volume of 113,607. The business’s fifty day simple moving average is $0.05 and its 200 day simple moving average is $0.05. MediPharm Labs has a twelve month low of $0.04 and a twelve month high of $0.09.

MediPharm Labs Company Profile

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products.